HomeNewsBusinessEconomyRBI to ensure 'comfortable level' of liquidity in system this fiscal
Trending Topics

RBI to ensure 'comfortable level' of liquidity in system this fiscal

To counter the impact of COVID-19 first wave, the RBI had undertaken several conventional and unconventional measures to ensure ample liquidity in the financial system during the financial year ended March 31, 2021.

May 27, 2021 / 16:17 IST
Story continues below Advertisement
Representative image
Representative image

The Reserve Bank on Thursday said it will ensure comfortable level of liquidity in the system during the current financial year and assured that monetary transmission will continue "unimpeded". To counter the impact of COVID-19 first wave, the RBI had undertaken several conventional and unconventional measures to ensure ample liquidity in the financial system during the financial year ended March 31, 2021.

"The Reserve Bank will ensure that system level liquidity remains comfortable during 2021-22 in alignment with the stance of monetary policy, and monetary transmission continues unimpeded while maintaining financial stability," according to the annual report 2020-21. This is exemplified by the introduction of the secondary market G-sec acquisition programme (G-SAP) in 2021-22 under which the RBI has committed upfront to a specific amount for open market purchases of G-secs with a view to enabling a stable and orderly evolution of the yield curve under congenial financial conditions, it said.

Story continues below Advertisement

RBI Annual Report: Stress tests indicate banks have sufficient capital even in severe scenario

The positive externalities of G-SAP 1.0 operations need to be seen in the context of those segments of the financial markets that rely on the G-sec yield curve as a pricing benchmark, it said, adding, the first tranche of the G-SAP of Rs 1 lakh crore has been received well and it has had a salutary effect on the evolution of G-sec yields. In an effort to boost provision of immediate liquidity for ramping up COVID related healthcare infrastructure and services in the country, the RBI last month announced an ontap liquidity window of Rs 50,000 crore with tenors of up to three years at the repo rate was opened till the end of 2021-22.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show